Health Care
Commentary
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Commentary
Medicaid’s Waivers Are Out of Control – But Also Show How to Save the Program
Are rental vouchers a form of “health care?” Federal bureaucrats evidently think so. They’ve recently approved waivers for states to fund these benefits through Medicaid, the joint federal-state health insurance program that covers over 76 million Americans. These waivers constitute an enormous federal subsidy to state governments, with up to ...
Blog
Read about Biden drug price control plan
The Damage from Price Controls on Pharmaceuticals Begins
The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
Commentary
Biden’s Disdain for Democracy Revealed in Backdoor Bailout
Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
Commentary
Scope-of-practice laws put patients in the crosshairs
New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
Commentary
JD Vance’s Healthcare Record Should Give Republicans Pause
The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
Commentary
Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets
Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary
Harris is wrong about medical debt
Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary
The Anti-Competitive Middlemen Harming Pharmacies And Patients
Astonishing drug innovations are improving the lives of patients including those living with cancer and autoimmune disorders. These innovations also expose the payment system’s fundamental flaws. The Federal Trade Commission’s (FTC) recently released interim report on pharmacy middlemen demonstrates that these flaws impose a high cost on patients and neighborhood pharmacies. These ...
Commentary
Read the latest on pharmaceutical benefit managers
Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.
The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Medicaid’s Waivers Are Out of Control – But Also Show How to Save the Program
Are rental vouchers a form of “health care?” Federal bureaucrats evidently think so. They’ve recently approved waivers for states to fund these benefits through Medicaid, the joint federal-state health insurance program that covers over 76 million Americans. These waivers constitute an enormous federal subsidy to state governments, with up to ...
Read about Biden drug price control plan
The Damage from Price Controls on Pharmaceuticals Begins
The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
Biden’s Disdain for Democracy Revealed in Backdoor Bailout
Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
Scope-of-practice laws put patients in the crosshairs
New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
JD Vance’s Healthcare Record Should Give Republicans Pause
The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets
Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Harris is wrong about medical debt
Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
The Anti-Competitive Middlemen Harming Pharmacies And Patients
Astonishing drug innovations are improving the lives of patients including those living with cancer and autoimmune disorders. These innovations also expose the payment system’s fundamental flaws. The Federal Trade Commission’s (FTC) recently released interim report on pharmacy middlemen demonstrates that these flaws impose a high cost on patients and neighborhood pharmacies. These ...
Read the latest on pharmaceutical benefit managers
Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.
The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
